BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
1.590
+0.003 (0.19%)
Aug 21, 2026, 4:00 PM EDT - Market closed
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $4.66 million as of August 24, 2026. Its market cap has decreased by -51.29% in one year.
Market Cap
4.66M
Enterprise Value
1.47M
1-Year Change
-51.29%
Ranking
Category
Stock Price
$1.59
ChartMarket Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $4.66M, a decrease of -88.93%. That is a compound annual growth rate of -31.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 4.66M | -50.05% |
| Dec 31, 2025 | 9.34M | 85.79% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hudson Technologies | 236.96M |
| Core Molding Technologies | 223.93M |
| Aemetis | 149.39M |
| Northern Technologies International | 76.83M |
| 5E Advanced Materials | 69.33M |
| Flexible Solutions International | 67.95M |
| Loop Industries | 29.95M |
| J-Star Holding | 7.22M |